Delhi High Court on Monday extended relief to the Pharma Companies by asking the government not to enforce ban until it has heard petitions from drugmakers challenging the order.
The court is scheduled to hear the plea of drug nakers on March 28.
Several companies, including Indian units of Abbott Laboratories and Pfizer Inc , and domestic firms like Cipla Ltd and Macleods Pharmaceuticals, went to the Delhi High Court to try to get the ban lifted.
Earlier this week, the health department prohibited the manufacture and sale of 344 fixed-dose combination drugs, citing experts as saying there was no medical justification to administer them.
According to reports, the full impact of the ban would be Rs. 3,800 crore a year on the Indian pharmaceutical industry.